Trends in hospitalization rates for inflammatory bowel disease in the United States

被引:130
作者
Bewtra, Meenakshi
Su, Chinyu
Lewis, James D.
机构
[1] Univ Penn, Dept Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA
[3] Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA
[4] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA
关键词
D O I
10.1016/j.cgh.2007.01.015
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: This study examined trends in hospitalization and surgery rates for inflammatory bowel disease (IBD) in the United States over a 14-year period. Methods: We performed an analysis of secular trends of hospitalization and surgery rates from Crohn's disease (CD) and ulcerative colitis (UC) using the 1990 to 2003 National Hospital Discharge Survey data. The Spearman correlation coefficient was used to examine the association between calendar year and rates of hospitalization or bowel resection surgery. Results: From 1990 to 2003, the hospitalization rates for patients with a primary diagnosis of IBD per 100,000 people ranged from 9.3 to 17.1 for CD and 8.2 to 12.4 for UC, with a significant trend for increasing hospitalization rates for CD (rho = .83, P = .0002) but not UC (rho = .06, P = .83). The annual rates of bowel resection surgeries per 100,000 people ranged from 2.8 to 5.0 for CD and from 1.6 to 3.4 for UC, with no significant trend for CD (rho = .30, P = .30) or UC (rho = -.31, P = .28). As expected, there was a significant trend for shorter hospitalizations for both CD (rho = -.98, P < .0001) and UC (rho = -.87, P < .0001). However, total hospital days did not change significantly for either CD or UC. Conclusions: Despite advances in therapy, IBD hospitalization and surgery rates in the United States have not decreased since 1990. Rather, there has been a significant increase in hospitalizations for CD, with stable rates of bowel resection surgery for CD and hospitalization and surgery for UC.
引用
收藏
页码:597 / 601
页数:5
相关论文
共 19 条
  • [1] Hospitalization, surgery, and readmission rates of IBD in Canada: A population-based study
    Bernstein, CN
    Nabalamba, A
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (01) : 110 - 118
  • [2] Integrating anti-tumor necrosis factor therapy in inflammatory bowel disease: Current and future perspectives
    Blam, ME
    Stein, RB
    Lichtenstein, GR
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2001, 96 (07) : 1977 - 1997
  • [3] Cohen RD, 2000, AM J GASTROENTEROL, V95, P3469
  • [4] Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery
    Cosnes, J
    Nion-Larmurier, I
    Beaugerie, L
    Afchain, P
    Tiret, E
    Gendre, JP
    [J]. GUT, 2005, 54 (02) : 237 - 241
  • [5] GOODMAN C, 2001, BURDEN GASTROINTESTI, P1
  • [6] Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
    Hanauer, SB
    Feagan, BG
    Lichtenstein, GR
    Mayer, LF
    Schreiber, S
    Colombel, JF
    Rachmilewitz, D
    Wolf, DC
    Olson, A
    Bao, WH
    Rutgeerts, P
    [J]. LANCET, 2002, 359 (9317) : 1541 - 1549
  • [7] INFLAMMATORY BOWEL-DISEASE - COSTS-OF-ILLNESS
    HAY, JW
    HAY, AR
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 1992, 14 (04) : 309 - 317
  • [8] COURSE OF ULCERATIVE-COLITIS - ANALYSIS OF CHANGES IN DISEASE-ACTIVITY OVER YEARS
    LANGHOLZ, E
    MUNKHOLM, P
    DAVIDSEN, M
    BINDER, V
    [J]. GASTROENTEROLOGY, 1994, 107 (01) : 3 - 11
  • [9] Lewis JD, 2002, AM J GASTROENTEROL, V97, P2540
  • [10] Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences
    Loftus, EV
    [J]. GASTROENTEROLOGY, 2004, 126 (06) : 1504 - 1517